A Cost-effectiveness Study of the Quadrivalent HPV6/11/16/18 Vaccination in a Two-dose Scheme in Girls of 9-11 Years Old Compared to Bivalent HPV 16/18 Vaccination in Ecuador and Challenges for Public Health and Screening